Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil in Rheumatoid Arthritis
NCT07730723Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Nicorandil group with Placebo group (2 arms). Primary endpoint: Evaluation of treatment Efficacy at 12 weeks. Started Sep 2026; status: recruiting.
02
Drugs
nicorandil
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07730723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730723.